Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weeks

Showing results (341-350 of 352) with videos related to

Pageof 36
Sort By:
Leukemia|February 26, 2026
Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicingJonas S Jutzi, Edie Crosse, Chulwoo J Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study GroupD M Green, N E Breslow, J B Beckwith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast CancerStefania Morganti, Christopher J Gibson, Qingchun Jin, et al.
European Heart Journal|November 12, 2023
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmiasArt Schuermans, Caitlyn Vlasschaert, Victor Nauffal, et al.
NPJ Biofilms and Microbiomes|September 11, 2021
Vaginal microbiome topic modeling of laboring Ugandan women with and without feverMercedeh Movassagh, Lisa M Bebell, Kathy Burgoine, et al.
Blood|June 17, 2022
TET2-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.
Leukemia|February 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasmsBenjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance StudyTia L Kauffman, Elizabeth K O'Donnell, Catherine R Marinac, et al.
BMJ Open|May 8, 2024
Strategies for optimising early detection and obstetric first response management of postpartum haemorrhage at caesarean birth: a modified Delphi-based international expert consensusVerónica Pingray, Caitlin R Williams, Fadhlun M Alwy Al-Beity, et al.
Blood Cancer Discovery|December 27, 2023
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal HematopoiesisCaner Saygin, Pu Zhang, Jacob Stauber, et al.
Pageof 36

Showing results (341-350 of 352) with videos related to

Sort By:
Pageof 36
Leukemia|February 26, 2026
Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicingJonas S Jutzi, Edie Crosse, Chulwoo J Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study GroupD M Green, N E Breslow, J B Beckwith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast CancerStefania Morganti, Christopher J Gibson, Qingchun Jin, et al.
European Heart Journal|November 12, 2023
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmiasArt Schuermans, Caitlyn Vlasschaert, Victor Nauffal, et al.
NPJ Biofilms and Microbiomes|September 11, 2021
Vaginal microbiome topic modeling of laboring Ugandan women with and without feverMercedeh Movassagh, Lisa M Bebell, Kathy Burgoine, et al.
Blood|June 17, 2022
TET2-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.
Leukemia|February 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasmsBenjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance StudyTia L Kauffman, Elizabeth K O'Donnell, Catherine R Marinac, et al.
BMJ Open|May 8, 2024
Strategies for optimising early detection and obstetric first response management of postpartum haemorrhage at caesarean birth: a modified Delphi-based international expert consensusVerónica Pingray, Caitlin R Williams, Fadhlun M Alwy Al-Beity, et al.
Blood Cancer Discovery|December 27, 2023
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal HematopoiesisCaner Saygin, Pu Zhang, Jacob Stauber, et al.
Pageof 36